[1]
Hughes RA, Cornblath DR. 2005."Guillain-Barré Syndrome," J. Lancet , 366:1653-66.
[2]
Bianchi G, Domenighetti G. 2006. "Pneumococcus pneumoniae and Guillain Barre Syndrome: for tuitous or specific association?" J. Intensive Care Med , 134:338-9.
[3]
White B, Diggle M, Todd A, Dundas S, et al.2011. "A novel pneumococcus with a new association. " J. Travel Med Infect Dis , 9(2):84-7.
[4]
W Song, YM Wu, Z Ji, JJ Zhu, et al. 2011."Guillain-Barré Syndrome following sepsis after stereotactic aspiration for spontaneous pintine hemorrhage." J. Neurol Sci ,Oct 18 [Epub ahead of print].
[5]
Kono Y, Nishitarumizu K, Higashi T, Funakoshi K, Odaka M.2007. "Rapidly progressive Guillain-Barré syndrome following Escherichia coli infection." J. Intern Med , 46(9):589-91.
[6]
S. Lorin, D.M. Nierman.2002. "Critical illness neuromuscular abnormalities,"J. Crit Care Clin, 18: 553–68.
[7]
L.H. Vissor. 2006."Critical illness polyneuropathy and myopathy: Clinical features, risk factors and prognosis,"J. Eur J Neurol ,13: 1203–12.
[8]
S. Lorin and D.M.Nierman. 2002."Critical illness neuromuscular abnormalities,"J. Crit Care Clin , 18: 553–68.
[9]
L.H. Vissor. 2006."Critical illness polyneuropathy and myopathy: Clinical features, risk factors and prognosis,"J. Eur J Neurol, 13: 1203–12.
[10]
Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. 1986."Critically ill Polyneuropathy electrophysiological studies and differentiation from Guillain-Barré syndrome." J. Neurol Neurosurg Psychiatry , 49: 563-73.
[11]
Yuki N, Hirata K.1999." Relation between CIP and axonal Guillain- Barré syndrome." J. Neurol Neurosurg Psychiatry ,67: 128-9.
[12]
Kaida K, Kusunoki S.2009. "Guillain-Barré Syndrome: undate on immunobiology and treatment."J. Expert Rev Neurother , 9:1307-19.
[13]
Yuki N. 2001."Infectious origins of and molecular mimicry in Guillain- Barré and Fisher syndromes."J. Lancet Infect Dis, 1: 29-37.
[14]
Kaida K, Kusunoki S. 2009."Guillain–Barre´syndrome: update on immunobiology and treatment."J. Expert Rev Neurother , 9:1307– 19.
[15]
Ortiz Leyba C. 2006." Pharmacological treatment neuromuscular impairments in critically ill patients."J. Nutr Hospl, 21 (suppl 3): 114-17.
[16]
Doherty N, Steen CD. 2010."Critical illness polyneuromyopathy (CIPNM); rehabilitation during critical illness. Therapeutic options in nursing to promote recovery: a review of the literature."J. Intensive Crit Care Nurs, 26(6):353-62.
